In this meta-analysis of randomized controlled trials, supplementation with silymarin improved metabolic parameters, liver enzymes, and liver disease severity in participants with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis.
This Study Summary was published on July 24, 2024.